IMPL   $0.22  -41.79% Market Closed

Impel Neuropharma Inc
Total Cash 239.00K
totalCashPerShare 0.01
EBITDA -68.96M
Total Debt 114.80M
quickRatio 0.055
currentRatio 0.188
Total Revenue 20.99M
debtToEquity
Revenue/Share 0.884
ROA -0.62491
ROE
grossProfits 6.16M
freeCashflow -57.81M
operatingCashflow -79.09M
earningsGrowth
revenueGrowth 0.63
grossMargins 0.5258
ebitdaMargins 0.0
operatingMargins -2.5504699
profitMargins 0.0
enterpriseValue 115.52M
forwardPE -0.27712643
floatShares 7.99M
sharesOutstanding 23.90M
sharesShort 851.50K
sharesShortPriorMonth 808.77K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.72%
Short Ratio help_outline 0.36%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue -3.87
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -74.28M
trailingEps -3.12%
forwardEps -0.87%
enterpriseToEbitda -1.68
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.21 4Q 2023
institutionsCount 41
lastUpdated Feb. 15, 2024, 3 a.m.